HIGHLIGHTS
- who: CITATION and collaborators from the University of Buea, Cameroon have published the Article: Commentary: A GSH/CB dual- controlled self-assembled nanomedicine for high-ef cacy doxorubicin-resistant breast cancer therapy, in the Journal: (JOURNAL)
- how: The results showed that various concentrations of cyclic1a promoted the apoptosis of MCF-7 doxorubicin resistant cells in a dose-dependent manner. The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
SUMMARY
With great interest, the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.